J. Curtis

发表

Hepatitis and epidemic hepatitis associated antigen (E.H.A.A.) in a haemodialysis unit with observations on haemoglobin levels.

M. S. Edwards, J. Eastwood, R. Fox, 1972, British journal of urology.

Hepatitis in a maintenance hemodialysis unit.

J. Eastwood, A. Wing, H. D. de Wardener, 1968, Annals of internal medicine.

Macroglossia and amyloidoma of the buttock: evidence of systemic involvement in dialysis amyloid.

E. Brown, D. Woodrow, D. Sethi, 1990, Nephron.

SHEDDING OF NAILS APPARENTLY INDUCED BY THE ADMINISTRATION OF LARGE AMOUNTS OF CEPHALORIDINE AND CLOXACILLIN IN TWO ANEPHRIC PATIENTS

J. Eastwood, H. E. Wardener, E. Smith, 1969, The British journal of dermatology.

Drug-induced Renal Disease

J. R. Curtis, J. Curtis, 1979, Drugs.

Survey of blood lead and plasma aluminium concentrations in patients of a renal unit.

S. Davies, B. Sampson, J. Curtis, 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Carbenicillin administration in patients with severe renal failure.

J. Eastwood, J. Curtis, 1968, British medical journal.

MORTALITY AND MORBIDITY OF LONG-TERM HAEMODIALYSIS

E. Maher, J. R. Curtis, J. Curtis, 1987, The Lancet.

Plasma renin concentration and the control of blood pressure in patients on maintenance haemodialysis.

J. Brown, A. Lever, J. Robertson, 1969, Nephron.

Antithrombotic Properties of Dermatan Sulphate (MF 701) in Haemodialysis for Chronic Renal Failure

M. Boisclair, H. Ireland, D. Lane, 1992, Thrombosis and Haemostasis.

Plasma ranitidine concentrations after intravenous administration in normal volunteers and haemodialysis patients.

G. Dixon, C. Harrison, A. Roberts, 1983, Postgraduate medical journal.

Objective assessment of heparin requirements for hemodialysis in humans.

H. Ireland, D. Lane, J. R. Curtis, 1984, The Journal of laboratory and clinical medicine.

The significance of fibrinogen derivatives in plasma in human renal failure

D. Lane, H. Ireland, D. Lane, 1984, British journal of haematology.

The Anticoagulant Effect of Heparinoid Org 10172 During Haemodialysis: An Objective Assessment

H. Ireland, D. Lane, H. Ireland, 1986, Thrombosis and Haemostasis.

Relationship between ex vivo anti‐proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222

H. Ireland, D. Lane, E. Thompson, 1988, British journal of haematology.

Maintenance haemodialysis.

P. Verroust, J. Eastwood, A. Wing, 1969, The Quarterly journal of medicine.

Megaloblastic anemia and pancytopenia due to Proguanil in patients with chronic renal failure.

M. Phillips, M. Boots, J. Curtis, 1982, Clinical nephrology.

Iron therapy in patients on maintenance haemodialysis.

M. S. Edwards, G. Pegrum, J. Curtis, 1970, Lancet.

AORTIC AND MITRAL VALVE CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE

E. Maher, S. Pugh, J. R. Curtis, 1987, The Lancet.

Survival in 200 patients treated by haemodialysis and renal transplantation.

J. Eastwood, P. Gower, F. Henari, 1977, British medical journal.

Expired breath oxidant activity during haemodialysis.

E. Maher, T. Dormandy, D. Wickens, 1989, Nephron.

The effect of maintenance haemodialysis and renal transplantation on the plasma testosterone levels of male patients in chronic renal failure.

K. G. Koutsaimanis, J. Daly, J. A. Zadeh, 1975, Acta endocrinologica.

Isolated glomerulonephritis with mesangial IgA deposits.

D. Woodrow, D. Evans, P. Gower, 1975, British medical journal.

Urinary iron loss in the nephrotic syndrome--an unusual cause of iron deficiency with a note on urinary copper losses.

E. Brown, B. Muller, B. Sampson, 1984, Postgraduate medical journal.

Is selenium deficiency the cause of uraemic cardiomyopathy?

E. Maher, B. Sampson, J. R. Curtis, 1987, Advances in experimental medicine and biology.

Acute metabolic alkalosis during haemodialysis.

D. Topham, D. Sethi, P. Gower, 1989, Nephron.

Increased free-radical activity during haemodialysis?

E. Maher, T. Dormandy, D. Wickens, 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Possible cobalt toxicity in maintenance hemodialysis patients after treatment with cobaltous chloride: a study of blood and tissue cobalt concentrations in normal subjects and patients with terminal and renal failure.

J. R. Curtis, J. Herrington, G. Goode, 1976, Clinical nephrology.

Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.

L. Talner, J. Eastwood, P. Gower, 1981, British medical journal.

The role of parathyroidectomy in the management of hyperparathyroidism in patients on maintenance haemodialysis and after renal transplantation.

C. Cochrane, J. Eastwood, P. Gower, 1982, Nephron.

Evaluation of doxycycline administration in patients with renal failure and in normal subjects.

J. Eastwood, K. G. Koutsaimanis, D. Buggey, 1973, British journal of urology.

Rhabdomyolysis and acute renal failure in chronic alcoholics with myopathy, unrelated to acute alcohol ingestion.

P. Parfrey, K. Sethi, D. Woodrow, 1984, Clinical nephrology.

Reproductive Potential of Patients Treated by Maintenance Haemodialysis

M. Elstein, J. R. Curtis, E. Smith, 1969, British medical journal.

Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.

R. Watts, E. Maher, S. Morgan, 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Low Molecular Weight Heparin in Haemodialysis for Chronic Renal Failure: Dose Finding Study of CY222

H. Ireland, D. Lane, A. Pegrum, 1988, Thrombosis and Haemostasis.

Disseminated infection with mycobacterium chelonei in a haemodialysis patient.

B. Azadian, J. Eastwood, P. Gower, 1981, Tubercle.

Dose Finding Study of a Low Molecular Weight Heparin, Innohep, in Haemodialysis

H. Ireland, D. Lane, A. Flynn, 1991, Thrombosis and Haemostasis.

Heparin and Low Molecular Weight Heparin(oid)s as Anticoagulants in Hemodialysis for Chronic Renal Failure

H. Ireland, D. Lane, A. Flynn, 1989 .

Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.

H. Ireland, D. Lane, E. Anastassiades, 1986, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Tetracycline Poisoning in Renal Failure

J. Eastwood, H. D. de Wardener, M. Phillips, 1974, British medical journal.

Cancer and patients with end-stage renal failure.

J. Curtis, 1982, British medical journal.

Acute haemolysis due to concentrated dialysis fluid.

P. Parfrey, E. Brown, M. Phillips, 1982, British medical journal.

Transient and Persistent Hypercalcaemia in Patients Treated by Maintenance Haemodialysis

J. Eastwood, A. Wing, H. D. de Wardener, 1968, British medical journal.

Accumulation of aluminium in chronic renal failure due to administration of albumin replacement solutions.

E. Brown, E. Maher, B. Sampson, 1986, British medical journal.

Serum ferritin in haemodialysis patients: is there a relationship to 'haemochromatosis alleles' HLA A3, B7, B14?

E. Maher, J. Curtis, 1986, Nephron.

Interventions in chronic renal failure.

J. Curtis, 1990, BMJ.

Reduction of clotting in Scribner shunts by long-term anticoagulation.

A. Wing, H. D. de Wardener, J. R. Curtis, 1967, British medical journal.

Pharmacodynamics of Practolol in Chronic Renal Failure

J. Eastwood, R. B. Smith, J. R. Curtis, 1973, British medical journal.

Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients.

J. R. Curtis, F. Bateman, J. Curtis, 1975, British medical journal.

On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failure.

H. Ireland, D. Lane, E. Anastassiades, 1986, Haemostasis.

The effect of systemic heparinisation and haemodialysis on plasma octadeca-9,11-dienoic acid (9,11-LA').

E. Maher, T. Dormandy, D. Wickens, 1987, Free Radical Research Communications.

Slow Sodium: An Oral Slowly Released Sodium Chloride Preparation

E. Clarkson, H. D. de Wardener, J. R. Curtis, 1971, British medical journal.

A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.

H. Ireland, D. Lane, E. Anastassiades, 1989, Clinical nephrology.

A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.

H. Ireland, D. Lane, E. Anastassiades, 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Drug-induced disorders of the urinary tract.

J. Curtis, 1980, British journal of hospital medicine.

Dermatan sulphate in haemodialysis

P. Stevens, M. Nurmohamed, H. Ireland, 1992, The Lancet.